S-AMLODIPINE AS A MODERN EFFECTIVE ANTIHYPERTENSIVE AND AN ANTIANGINAL AGENT

Author:

Chopei Ivan V.1,Chubirko Ksenia I.1,Bychko Mykhailo V.1,Hechko Mykhaylo M.1,Kedyk Antonina V.1,Kogutych Ivan I.1

Affiliation:

1. UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE

Abstract

The aim: Study of the clinical and hemodynamic effects of S-amlodipine in patients with arterial hypertension associated with coronary artery disease, in individuals with preserved LV systolic function. Materials and methods: The study includes 51 patients with arterial hypertension associated with coronary artery disease, who were treated with S-amlodipine. Results: This study shows the high clinical effectiveness of the use of S-amlodipine in patients with arterial hypertension associated with coronary artery disease. We reveal that treatment of hypertensive patients with coronary artery disease with S-amlodipine leads to improvement of LV diastolic dysfunction, bringing it closer to normal values. Conclusions: Clinical effectiveness was associated with positive changes in hemodynamics, and was expressed in the normalization of the left ventricle diastolic function parameters, about which indirectly indicates decreasing of end-diastolic pressure.

Publisher

ALUNA

Subject

General Medicine

Reference16 articles.

1. 1. Amosova KM. Porivnialna otsinka antyanhinalnoi efektyvnosti ta perenosymosti livoobertaiuchoho izomeru amlodypinu i oryhinalnoho amlodypinu u khvorykh na esentsialnu arterialnu hipertenziiu. [Comparative assessment of the antianginal efficacy and tolerability of the levorotatory isomer of amlodipine and the original amlodipine in patients with essential arterial hypertension]. Spetsializovanyy medychnyy portal. 2015. https://health-ua.com/article/15521-porvnyalna-otcnka-antigpertenzivno-efektivnost-ta-perenosimost-lvoobertayuc [date access 20.05.2023] (In Ukrainian).

2. 2. Bychko MV. Antahonisty kaltsiiu v likuvanni khvorykh na arterialnu hipertenziiu asotsiiovanu iz ishemichnoiu khvoroboiu sertsia [Calcium antagonists in the treatment of patients with arterial hypertension associated with coronary heart disease]. Uzhhorod: Lira. 2019, p. 248. https://dspace.uzhnu.edu.ua/jspui/handle/lib/47306 [date access 20.05.2023] (In Ukrainian).

3. 3. Sen S, Demir M, Yigit Z, Üresin AY. Efficacy and safety of S-amlodipine 2.5 and 5 mg/d in hypertensive patients who were treatment-naive or previously received antihypertensive monotherapy. J Cardiovasc Pharmacol Ther. 2018;23(4):318-328. doi: 10.1177/1074248418769054.

4. 4. Dalal J, Mohan JC, Iyengar SS et al. S-Amlodipine: an isomer with difference-time to shift from racemic amlodipine. Int J Hypertens. 2018; 2918:8681792. doi: 10.1155/2018/8681792.

5. 5. Lutai MI, Lysenko HF. Efektyvnist preparatu amlodypinu (stamlo) u patsiientiv z ishemichnoiu khvoroboiu sertsia v poiednanni z arterialnoiu hipertenziieiu [The effectiveness of the drug amlodipine (stamlo) in patients with coronary heart disease in combination with arterial hypertension]. Ukr. kardiol. zhurn. 2001; 2: 87-99. (In Ukrainian).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3